1. Generics Bulletin

Dr Reddy’s Gears For Sputnik Pediatric Shot, Molnupiravir Upside

 
• By Anju Ghangurde

Dr Reddy’s indicates it is close to break-even between “the investment made and what we gained” for Russian COVID-19 vaccine Sputnik V in India, with Sputnik Light, boosters and pediatric shots seen as the new growth drivers. The company’s fully vertically integrated operations also puts it in prime position for supplies of antiviral molnupiravir.

sputnik
Dr Reddy's Primes Life Cycle Management Plans For Sputnik • Source: Alamy

Supply inconsistencies may have dulled Russian COVID-19 vaccine Sputnik V’s early run in India, but partner Dr Reddy's Laboratories is working on a three-forked approach to tap new opportunities for the immunization shot, including plans for booster and pediatric doses.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Generics Bulletin for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Archive

More from Generics Bulletin